Results 211 to 220 of about 1,086,070 (250)

Multidrug resistant cervical tuberculosis

American Journal of Otolaryngology, 1999
Tuberculosis (TB) remains a global health problem, with an annual incidence of 8 to 10 million cases and the death of 3 million people year1y.l Despite the continuous decline of TB in the United States since the 185Os, an increase in new TB cases was observed in 1985.
A J, Vartanian, A, Alvi
openaire   +2 more sources

Treatment of multidrug-resistant tuberculosis

Journal of Hospital Infection, 1995
Recent outbreaks of multi-drug-resistant tuberculosis (MDR-TB) have resulted in significant morbidity and mortality in patients with AIDS. The poor outcomes are attributable to delayed diagnoses, slow reporting of antimycobacterial susceptibility results, inadequate treatment regimens and profound immunosuppression.
openaire   +2 more sources

The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis

New England Journal of Medicine, 2009
The diarylquinoline TMC207 offers a new mechanism of antituberculosis action by inhibiting mycobacterial ATP synthase. TMC207 potently inhibits drug-sensitive and drug-resistant Mycobacterium tuberculosis in vitro and shows bactericidal activity in patients who have drug-susceptible pulmonary tuberculosis.In the first stage of a two-stage, phase 2 ...
Diacon, A. H., Pym, A., Grobusch, M., Patientia, R., Rustomjee, R., Page-Shipp, L., Pistorius, C., Krause, R., Bogoshi, M., Churchyard, G., Venter, A., Allen, J., Palomino, J. C., De Marez, T., van Heeswijk, R. P. G., Lounis, N., Meyvisch, P., Verbeeck, J., Parys, W., de Beule, K., Andries, K., McNeeley, D. F.   +21 more
openaire   +4 more sources

Management of Multidrug-Resistant Tuberculosis

Chemotherapy, 1999
Drug-resistant tuberculosis (TB) originally is the product of inadequate therapy; this may entail noncompliance with treatment, interrupted drug supplies, or inappropriate prescription. Patients may sequentially acquire resistance to several drugs through repetition of this process.
openaire   +2 more sources

The challenge of multidrug resistant tuberculosis

Hospital Medicine, 2001
Multidrug resistant tuberculosis (MDRTB) is defined as resistance to the two principal drugs used to treat TB, isoniazid and rifampicin, whether there is resistance to other drugs or not. It is a relatively new phenomenon and poses one of the most difficult therapeutic problems in medicine because failure may not only mean death of the patient but ...
openaire   +2 more sources

Testicular tuberculosis in multidrug-resistant pulmonary tuberculosis

Journal of Infection and Chemotherapy, 2013
We report a rare case of multidrug-resistant pulmonary and testicular tuberculosis (TB) in a 25-year-old immunocompetent patient. The patient was suspected to have a testicular cancer. He underwent radical orchiectomy, and surgical pathology revealed a granuloma containing acid-fast bacilli in the testis.
Joo Wan, Seo, Chang Jun, Park, Tae Kyun, Kim, Jeong Ha, Mok, Mi Hyun, Kim, Kwangha, Lee, Ki Uk, Kim, Hye-Kyung, Park, Min Ki, Lee   +8 more
openaire   +2 more sources

Quinolones and Multidrug-Resistant Tuberculosis

Chemotherapy, 1999
The prevalence of initial resistance of multidrug-resistant tuberculosis (MDR-TB) to at least isoniazid (INH) and rifampicin (RFP) in Thailand during the period 1993–1997 is reported; in this era, trends for INH + RFP + streptomycin (SM) and ethambutol (EMB), INH + RFP + SM or EMB and MDR-TB were stable. The prevalence of acquired MDR-TB is on a slight
openaire   +2 more sources

Multidrug-Resistant Tuberculosis

JAMA, 2005
DURING THE PAST DECADE MULTIDRUG-RESISTANT TUberculosis (MDR-TB) defined as resistance to at least isoniazid and rifampin has declined in the United States. The number of reported MDR-TB cases has decreased from 486 in 1993 to 114 in 2003 and the proportion of resistant strains of Mycobacterium tuberculosis has decreased by half.
openaire   +2 more sources

[Multidrug-resistant tuberculosis. 4. Treatment and prognosis of multidrug-resistant tuberculosis].

Kekkaku : [Tuberculosis], 1999
We studied the clinical characteristics, treatment and prognosis of multidrug-resistant pulmonary tuberculosis patients retrospectively. In this study, multidrug-resistant is defined as both resistant to 0.1 microgram/ml of INH and 50 micrograms/ml of RFP at least.
M, Ogawara, M, Sakatani
openaire   +1 more source

Multidrug-Resistant ESBL-Producing E. coli in Clinical Samples from the UK

Antibiotics, 2023
Mathew Diggle, Dov Stekel, Michelle M Lister   +2 more
exaly